Literature DB >> 25653970

Prescribing Pattern of Anti-malarial Drugs with Particular Reference to the use of Artesunate in Complicated Plasmodium Vivax Cases.

Ashutosh Kumar Singh1, Mohd Sajid Khan1, Farhan Ahmad Khan2.   

Abstract

BACKGROUND: In developing countries, Malaria has been found to be one of the most common cause of fever and morbidity, particularly among infants and young children. Therefore, its drug utilization studies should be carried out to know the rationality of treatment. AIM: To evaluate the use of antimalarial agents in children with a diagnosis of Malaria and visited to OPD & IPD Paediatric department of a tertiary care teaching hospital.
MATERIALS AND METHODS: This was a prospective six months study based on a Medication Utilization Form, which has been designed in consultation with the paediatrician. One hundred eighty three children <12 y of age were selected on the basis of inclusion and exclusion criteria.
RESULTS: Out of 183 patients, 110 were infected with Plasmodium falciparum (60.10%) and 73 with Plasmodium vivax (39.89%). Most of the patients were male, 56.83% and 43.16% were female patients. Most of the complicated cases were found from Plasmodium falciparum (n = 110) than Plasmodium vivax (n=15). In prescriptions with monotherapy, Artesunate (n=101) was found to be the most commonly prescribed drug and in prescriptions containing more than one drug, Artesunate - lumefantrine (n=125) combinations were frequently used. Most of the drugs were prescribed by oral route (n=285), than the parenteral route (n=140). The average number of drugs per encounter was 2.32 and only 4.50% drugs were prescribed by generic name. Average drug cost per prescription in complicated cases was found to be higher (185.5 INR) than uncomplicated cases (115 INR).
CONCLUSION: Artemisinin were used as first line drugs irrespective of the causative agent for malaria, which is not recommended, however has been found to be effective in complicated cases of Plasmodium vivax also. The cost of the prescription was higher. Interventions to rectify over prescription of injectables necessary to further improve rational drug use in our facility. Also, there should be an awareness program, especially in slum areas to cut down the transmission of disease.

Entities:  

Keywords:  Artesunate; Drug utilization study; Essential drugs; Lumefantrine; Malaria

Year:  2014        PMID: 25653970      PMCID: PMC4316276          DOI: 10.7860/JCDR/2014/11253.5336

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  7 in total

1.  Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria.

Authors:  N J White; P L Olliaro
Journal:  Parasitol Today       Date:  1996-10

Review 2.  Emergency department management of mosquito-borne illness: malaria, dengue, and West Nile virus.

Authors:  Hector Caraballo; Kevin King
Journal:  Emerg Med Pract       Date:  2014-05

Review 3.  Re-emergence of malaria in India.

Authors:  V P Sharma
Journal:  Indian J Med Res       Date:  1996-01       Impact factor: 2.375

Review 4.  Malaria in South Asia: prevalence and control.

Authors:  Ashwani Kumar; Laura Chery; Chinmoy Biswas; Nagesh Dubhashi; Prafulla Dutta; Virendra Kumar Dua; Mridula Kacchap; Sanjeeb Kakati; Anar Khandeparkar; Dalip Kour; Satish N Mahajan; Ardhendu Maji; Partha Majumder; Jagadish Mohanta; Pradyumna K Mohapatra; Krishnamoorthy Narayanasamy; Krishnangshu Roy; Jayanthi Shastri; Neena Valecha; Rana Vikash; Reena Wani; John White; Pradipsinh K Rathod
Journal:  Acta Trop       Date:  2012-01-08       Impact factor: 3.112

5.  Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations.

Authors:  Emiliana Tjitra; Joanne Baker; Sri Suprianto; Qin Cheng; Nicholas M Anstey
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

6.  Plasmodium vivax malaria.

Authors:  Dhanpat K Kochar; Vishal Saxena; Narvachan Singh; Sanjay K Kochar; S Vijay Kumar; Ashis Das
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

Review 7.  Battling malaria iceberg incorporating strategic reforms in achieving Millennium Development Goals & malaria elimination in India.

Authors:  V P Sharma
Journal:  Indian J Med Res       Date:  2012-12       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.